Lipid nanoparticle-encapsulated mRNA antibody provides long-term protection against SARS-CoV-2 in mice and hamsters

Monoclonal antibodies represent important weapons in our arsenal to against the COVID-19 pandemic. However, this potential is severely limited by the time-consuming process of developing effective antibodies and the relative high cost of manufacturing. Herein, we present a rapid and cost-effective l...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Yong-Qiang, Zhang, Na-Na, Zhang, Yi-Fei, Zhong, Xia, Xu, Sue, Qiu, Hong-Ying, Wang, Tie-Cheng, Zhao, Hui, Zhou, Chao, Zu, Shu-Long, Chen, Qi, Cao, Tian-Shu, Ye, Qing, Chi, Hang, Duan, Xiang-Hui, Lin, Dan-Dan, Zhang, Xiao-Jing, Xie, Liang-Zhi, Gao, Yu-Wei, Ying, Bo, Qin, Cheng-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866932/
https://www.ncbi.nlm.nih.gov/pubmed/35210606
http://dx.doi.org/10.1038/s41422-022-00630-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866932/
https://www.ncbi.nlm.nih.gov/pubmed/35210606
http://dx.doi.org/10.1038/s41422-022-00630-0

Ejemplares similares